Search

Your search keyword '"Sakai-Tagawa, Yuko"' showing total 2 results
2 results on '"Sakai-Tagawa, Yuko"'

1. Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75.

Author

Emi Takashita, Selya Yarnayoshi, Yoshihiro Kawaoka, Takashita, Emi, Yamayoshi, Seiya, Fukushi, Shuetsu, Suzuki, Tadaki, Maeda, Ken, Sakai-Tagawa, Yuko, Ito, Mutsumi, Uraki, Ryuta, Halfmann, Peter, Watanabe, Shinji, Takeda, Makoto, Hasegawa, Hideki, Imai, Masaki, and Kawaoka, Yoshihiro

Subjects
*IMMUNOGLOBULINS, *ANTIVIRAL agents, *RESEARCH funding, *VIRAL antibodies
Published
2022
Full Text
View/download PDF

2. Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants.

Author

Emi Takashita, Seiya Yarnayoshi, Yoshihiro Kawaoka, Takashita, Emi, Yamayoshi, Seiya, Simon, Viviana, van Bakel, Harm, Sordillo, Emilia M, Pekosz, Andrew, Fukushi, Shuetsu, Suzuki, Tadaki, Maeda, Ken, Halfmann, Peter, Sakai-Tagawa, Yuko, Ito, Mutsumi, Watanabe, Shinji, Imai, Masaki, Hasegawa, Hideki, and Kawaoka, Yoshihiro

Subjects
*IMMUNOGLOBULINS, *MONOCLONAL antibodies, *ANTIVIRAL agents, *VIRAL antibodies
Abstract

The article discusses The data from our trial suggest that dulaglutide , if ultimately approved for pediatric use, may offer advantages not only with regard to glycemic control but also with regard to its frequency and method of administration. Weekly administration with a device that does not require reconstitution steps or needle handling and that has shown favorable ease-of-use characteristics in preference studies involving.

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results